Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals
Author(s) -
Keisuke Fukuchi,
Kayoko Nanai,
Hiroshi Yuita,
Chikako Maru,
Jun Tsukada,
Masato Ishigami,
Yoko Nagai,
Yoko Nakano,
Chigusa Yoshimura,
Kozo Yoneda,
Masato Amano,
Kensuke Nakamura,
Yoko Oda,
Haruyuki Nishigohri,
S Yamamoto,
Yusuke Ohnishi-Totoki,
Koichiro Inaki,
Hironobu Komori,
Rika Nakano,
Yoshiyuki Kanari,
Atsuko Nishida,
Yumi Matsui,
Satoko Funo,
Sayako Takahashi,
Toshiaki Ohtsuka,
Toshinori Agatsuma
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/3552793
Subject(s) - cd44 , cancer research , antibody , medicine , monoclonal antibody , kinase , cell culture , downregulation and upregulation , integrin , mapk/erk pathway , cell , receptor , immunology , microbiology and biotechnology , biology , biochemistry , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom